Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
n-[3-(n'-hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the formula C19H29N3O5 and a molecular weight of approximately 379.5 g/mol. It is known by several code names, including SC-44463 and CHEMBL45483. The drug has been referenced in chemical and pharmacological databases as an experimental agent, but there is no evidence of clinical development or approved therapeutic use as of June 2025. Its mechanism of action, primary indication, developer, or specific biological activity are not described in available public sources[1][3]. It appears to be primarily studied at the preclinical or chemical research level.
- Other names
- (2R)-N'-hydroxy-N-((1S)-2-(4-methoxyphenyl)-1-(methylcarbamoyl)ethyl)-2-(2-methylpropyl)butanediamide(2R)-N'-hydroxy-N-[(1S)-2-(4-methoxyphenyl)-1-(methylcarbamoyl)ethyl]-2-(2-methylpropyl)butanediamideN-(3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL)-O-TYROSINE-N-METHYLAMIDEN-[3-(N'-Hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-O-Tyrosine-N-Methylamide
Beyond the preview
Go deeper on n-[3-(n'-hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on n-[3-(n'-hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamide.